Marc Lichtenfeld | TalkMarkets | Page 4
Equities Analyst by Day/Ring Announcer by Night
Marc is the Chief Income Strategist for The Oxford Club and Wealthy Retirement, as well as Founder and Senior Editor of The Oxford Income Letter. He also contributes frequently to The Oxford Communiqué and Investment U. Marc is Editor of VIP Trading Services Dividend Multiplier, Oxford ...more

All Contributions

Latest Posts
49 to 64 of 566 Posts
<<< 1 2 3 4 5 6 ... 36 >>>
A Few Simple Steps To Offset Inflation
Life is expensive. Everyone needs to ensure that their money is earning as much as possible to keep up with these insane price increases.
Global Net Lease: Is This 16% Yield “Stable”?
Global Net Lease is a real estate investment trust that focuses on commercial properties.
The Recession That Isn't Happening
More international money is being invested in the U.S. than in any other nation. In 2021, 30% of all dollars invested in another country were invested in the U.S.
Medical Properties Trust: This 9% Yield Is No Longer Safe
Medical Properties Trust is a landlord for hospitals and is the second-largest nongovernmental owner of hospitals in the world.
Is This The Perfect Time To Buy Bonds?
You can always find a reason not to invest. But there’s a way you can invest your cash, earn interest, and not worry about losing money - Bonds.
Can OneMain Holdings Sustain Its Double-Digit Yield?
The company pays a $1 per share quarterly dividend, which comes out to a 10% annual yield. It has raised its dividend every year since it began paying one in 2019.
The Truth About IPO Investing
When most companies go public, they are somewhat mature. Tech company initial public offerings, or IPOs, are a bit different, however. These companies are often not yet profitable. And biotech IPOs are a special animal altogether.
ARCC Stock: Did This 10% Yielder Get Safer?
Ares Capital doesn’t raise its dividend every year, but it has boosted it four times in the past four years, after several years of keeping it steady.
Three Lessons For Investing In Biotech Companies
Many successful blockbusters started with a small trial. But you should temper your expectations until a larger, more rigorous trial is conducted.
How To Invest In The Healthcare Sector
If things go wrong with some healthcare companies, investors often justify why they stay in the stock. And when things go right, they can go right in a hurry. Mersana Therapeutics is an example of how biotech stocks can experience these big swings.
PEAK Stock: How Healthy Is This 5.9% Yield?
Healthpeak Properties has cut its dividend several times in the recent past. Today, the dividend is nearly half of what it was in 2015.
EOG Stock: Can Income Investors Stay Lucky With This Dividend Payer?
EOG Resources currently pays a $0.825 per share quarterly dividend, or $3.30 annually, which comes out to a 2.5% yield.
What America’s Debt Downgrade Means For Investors
Fitch’s downgrade could make our debt more expensive. Typically, the lower the rating, the higher the interest rate the issuer has to pay.
Dow Stock: Does A 125-Year History Make This 5% Yield Safe?
Dow pays $2 billion in dividends, so the projected payout ratio is a comfortable 67%. As a result of the deteriorating free cash flow and the limited dividend history, it’s hard to declare the dividend safe.
AGNC Stock: Can This Company Finally Sustain Its Double-Digit Yield?
When a company shows you it is a serial dividend cutter, believe it.
Don’t Live In Fear Of A Market Crash
The global economy shut down in March 2020 due to the pandemic. We’d never seen anything like that before. Six months later, the market was at new highs.
49 to 64 of 566 Posts
<<< 1 2 3 4 5 6 ... 36 >>>